Cyclerion Therapeutics stockholders elect directors and ratify auditor at 2022 annual meeting

Cyclerion Therapeutics, Inc.

Elected eight directors: Conrades, De Souza, Fanucci, Hecht, Isacson, Lovell, McGuire, Mendelsohn; each received over 22.4 million votes for.
Ratified Ernst & Young as independent auditor for fiscal 2022 with 30,226,143 votes for, 53,476 against, 13,639 abstain.
Broker non-votes totaled 7,253,724 on all director elections.
Annual meeting held June 14, 2022; all proposals passed as recommended by the board.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.